Companies
From start-ups to market leaders, access critical company intelligence on a global scale
Experience what our solutions have to offer with free access to highlights of our data, insights and analysis.
From start-ups to market leaders, access critical company intelligence on a global scale
From industry deep dives to global trends, access authoritative research from our experts
Uncover your next opportunity with trusted data & insights that cut across industries
Discover the disruptive forces shaping tomorrow's world, today
Explore our diverse collection of unique datasets and find the advantage you need
Get clarity into the latest emerging themes with our reports
Experience what our solutions have to offer with free access to highlights of our data, insights and analysis.
From start-ups to market leaders, access critical company intelligence on a global scale
From industry deep dives to global trends, access authoritative research from our experts
Uncover your next opportunity with trusted data & insights that cut across industries
Discover the disruptive forces shaping tomorrow's world, today
Explore our diverse collection of unique datasets and find the advantage you need
Get clarity into the latest emerging themes with our reports
Immuno-Oncology Market Report
Immuno-oncology is uniquely positioned to become the fifth pillar of cancer treatment alongside surgery, radiotherapy, chemotherapy, and other targeted treatments.
We want to assist you with navigating the burgeoning amount of information arising as a result of the rapidly growing field of Immuno-Oncology market and clinical research, and this report will help you achieve this. The report consists of a highly-visual slide deck intended to facilitate the distribution of aggregated data and insights from analyses of over 800 I-O products that are either marketed or in Phase I-III of clinical development.
Our report provides unique, actionable insights applicable to I-O drugs in five major categories: Immune Checkpoint Modulators (Monoclonal Antibodies & Small Molecules), Cellular Immunotherapies (Cytotoxic Cellular Immunotherapies & Call-Based Vaccines), Oncolytic Viruses, Peptide Vaccines, and Bispecific T-Cell Engagers – you won’t find this information elsewhere. GlobalData analyzes over 4,000 clinical trials to generate a truly unique insight. A total of 18 solid tumor types and 8 hematological cancers are covered.
The field of I-O involves development of therapies that can harness the body’s ability to generate and sustain an effective immune response against cancer. GlobalData selected I-O products based on their molecular targets and molecular types. KOLs share their enthusiasm about I-O therapies that have impacted various oncology indications.